文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

MicroRNA-21是脓毒症多器官保护中局部与远端缺血预处理的必需分子

MicroRNA-21 Is Required for Local and Remote Ischemic Preconditioning in Multiple Organ Protection Against Sepsis.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论小鼠实验显示,15分钟双侧肾蒂夹闭的肾缺血预处理可减轻内毒素血症或盲肠结扎穿孔所致多器官损伤,该保护作用依赖microRNA-21。

本研究为实验室研究,使用小鼠肾小管上皮细胞、C57BL/6J野生型小鼠及microRNA-21-/-小鼠。肾缺血预处理通过双侧肾蒂夹闭15分钟诱导,脓毒症通过单次腹腔注射脂多糖20 mg/kg或盲肠结扎穿孔诱导。肾缺血预处理可保护肾脏、心脏、肝脏和肺免受内毒素血症或 polymicrobial 脓毒症所致多器官损伤,机制涉及缺氧诱导因子-1α上调microRNA-21、血清外泌体及远端器官microRNA-21表达增加、凋亡减少和促炎细胞因子产生减少。体内敲低或基因敲除microRNA-21可消除该器官保护效应。作者认为microRNA-21上调可能是脓毒症的潜在治疗方向。

要点

  • 小鼠中,双侧肾蒂夹闭15分钟的肾缺血预处理可减轻脂多糖20 mg/kg或盲肠结扎穿孔所致肾脏、心脏、肝脏和肺的多器官损伤。
  • 肾缺血预处理后肾脏缺氧诱导因子-1α激活,在转录水平上调microRNA-21,使血清外泌体和远端器官microRNA-21表达增加。
  • 体内敲低microRNA-21或microRNA-21基因敲除可消除肾缺血预处理对脓毒症多器官损伤的保护作用。
  • 机制上,敲低microRNA-21增加程序性细胞死亡蛋白4表达和核因子-κB活性,降低抗凋亡B细胞淋巴瘤-2表达。
  • 作者认为microRNA-21上调可能是脓毒症的潜在治疗方向。

适用人群与场景

  • 小鼠肾小管上皮细胞、C57BL/6J野生型小鼠及microRNA-21-/-小鼠(B6.129-Mir21atm1Smoc)。
  • 脓毒症模型为单次腹腔注射脂多糖20 mg/kg或盲肠结扎穿孔诱导的小鼠。

处置流程与药物剂量

  • 肾缺血预处理:双侧肾蒂夹闭15分钟。
  • 脓毒症诱导:单次腹腔注射脂多糖20 mg/kg,或盲肠结扎穿孔。
  • 细胞处理:小鼠肾小管上皮细胞给予缺氧(2%氧气)处理。

研究设计与关键结果

  • 实验室研究:肾缺血预处理小鼠免受内毒素血症或 polymicrobial 脓毒症所致多器官损伤,包括肾脏、心脏、肝脏和肺。
  • 肾缺血预处理诱导肾脏缺氧诱导因子-1α激活,转录水平上调microRNA-21,随后血清外泌体和远端器官microRNA-21表达增加,这些器官凋亡减少、促炎细胞因子产生减少。
  • 体内敲低microRNA-21或microRNA-21基因敲除可消除肾缺血预处理赋予的器官保护效应。
  • 机制上,敲低microRNA-21增加程序性细胞死亡蛋白4表达和核因子-κB活性,降低抗凋亡B细胞淋巴瘤-2表达。

证据类型、等级与局限

  • 证据类型:实验室研究(小鼠细胞及动物实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为microRNA-21上调可能是脓毒症的潜在治疗方向。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Sepsis, triggered by microbial infection, is a common and life-threatening systemic illness, often leads to impaired function of vital organs. Ischemic preconditioning induced by transient brief episodes of ischemia is a powerful innate mechanism of organ protection. We have reported that a 15-minute renal ischemic preconditioning substantially attenuated subsequent renal ischemia-reperfusion injury. Here, we investigate whether a brief ischemia and reperfusion in kidney can provide protection at local and remote sites against sepsis-induced organ injury, and whether this protection is microRNA-21 dependent.

DESIGN: Laboratory study.

SETTING: University laboratory.

SUBJECTS: Mouse renal tubular epithelial cells, C57BL/6 J wildtype (Animal Center of Fudan University, Shanghai, China) and microRNA-21-/- mice (B6.129-Mir21atm1Smoc, Shanghai Biomodel Organism Science & Technology Development Co. Shanghai, China).

INTERVENTIONS: Mouse renal tubular epithelial cells were treated with hypoxia (2% oxygen). Renal ischemic preconditioning was induced by bilateral renal pedicle clamping for 15 minutes, and sepsis was induced by a single intraperitoneal injection of lipopolysaccharide at a dose of 20 mg/kg or cecal ligation and puncture in mice.

MEASUREMENTS AND MAIN RESULTS: Mice treated with renal ischemic preconditioning were protected from endotoxemia or polymicrobial sepsis-induced multiple organ injury, including kidneys, heart, liver, and lungs. Renal ischemic preconditioning induced activation of hypoxia-inducible factor-1α in kidneys, which up-regulated microRNA-21 at transcriptional level, subsequently, leading to increased expression of microRNA-21 in serum exosomes and remote organs, resulting in decreased apoptosis and reduced proinflammatory cytokines production in these organs. In vivo knockdown of microRNA-21 or genetic deletion of microRNA-21 abrogated the organoprotective effects conferred by renal ischemic preconditioning. Mechanistically, we discovered that knockdown of microRNA-21 increased programmed cell death protein 4 expression and nuclear factor-kappa B activity, decreased expression of anti-apoptotic B-cell lymphoma-2.

CONCLUSION: MicroRNA-21 is required for local and remote ischemic preconditioning in multiple organ protection against sepsis, and up-regulation of miR-21 may be a potential therapy for sepsis.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jia P, Wu X, Dai Y, et al. MicroRNA-21 Is Required for Local and Remote Ischemic Preconditioning in Multiple Organ Protection Against Sepsis. Crit Care Med. 2017. PMID: 28437377. doi:10.1097/CCM.0000000000002363

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。